Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 81.90%-256.8K | 114.58%382.4K | 3,775.03%462.94K | -273.07%-5.7M | -309.71%-1.64M | 58.84%-1.42M | 36.26%-2.62M | -100.24%-12.6K | -121.71%-1.53M | -93.74%782.68K |
| Net income from continuing operations | -238.95%-3.99M | -259.86%-559.11K | 66.36%2.2M | -20,721.68%-9.13M | -30.43%-9.62M | -116.17%-1.18M | 115.72%349.75K | -41.89%1.32M | 99.28%-43.84K | -316.26%-7.38M |
| Operating gains losses | 14.98%700.34K | -114.48%-225.02K | 254.97%1.01M | -55.49%1.91M | -90.64%402.01K | 8,490.72%609.08K | 51,790.75%1.55M | -162,681.80%-652.76K | 672.18%4.3M | 991.57%4.29M |
| Depreciation and amortization | -95.23%29.22K | -52.94%36.02K | -42.59%115.23K | -73.79%1.39M | -69.05%498.71K | -1.04%611.86K | -91.79%76.54K | -90.59%200.72K | 231.75%5.29M | 21.37%1.61M |
| Asset impairment expenditure | 58,463,736.36%6.43M | --0 | --0 | 544.93%10.04M | 1,338.16%10.03M | -100.00%-11 | ---58 | --7.81K | -50.54%1.56M | -77.84%697.59K |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Remuneration paid in stock | -99.76%1.59K | -50.29%16.96K | --0 | -55.86%1.06M | -94.02%38.71K | 8.54%650.69K | -96.58%34.12K | 117.45%334.71K | 13.14%2.4M | 23.13%646.94K |
| Deferred tax | -152.70%-1.07M | 8.84%1.16M | -83.88%137.83K | 31.54%2.45M | -180.93%-1.51M | --2.03M | --1.07M | --854.95K | --1.86M | --1.86M |
| Other non cashItems | 19.16%-2.75M | 69.43%-1.72M | 29.41%-3.92M | 3.47%-16.71M | -63.85%-2.12M | 67.08%-3.4M | -76.58%-5.63M | -123.17%-5.56M | -1,118.26%-17.31M | 19.38%-1.29M |
| Change In working capital | 153.55%395.63K | 2,414.76%1.67M | -73.40%925.36K | 676.20%3.3M | 84.88%632.87K | 70.15%-738.81K | 88.45%-72.3K | 9.28%3.48M | -93.81%425.28K | -96.76%342.32K |
| -Change in receivables | 99.06%-11.16K | -165.21%-92.67K | -9.59%477.69K | -102.02%-29.3K | 148.12%490K | -277.23%-1.19M | -28.04%142.1K | -66.94%528.39K | 136.59%1.45M | 66.99%-1.02M |
| -Change in prepaid assets | -100.02%-46 | 109.63%12.77K | -53.52%186.35K | 140.37%273.36K | 56.18%-207.36K | 200.59%212.46K | -126.59%-132.64K | 181.56%400.9K | 23.33%-677.17K | -112.43%-473.15K |
| -Change in payables and accrued expense | 70.57%406.83K | 2,244.74%1.75M | -89.75%261.32K | 982.51%3.06M | -80.90%350.23K | 108.13%238.52K | 93.82%-81.76K | 22.77%2.55M | -102.96%-346.4K | -81.39%1.83M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 81.90%-256.8K | 114.58%382.4K | 3,775.03%462.94K | -273.07%-5.7M | -309.71%-1.64M | 58.84%-1.42M | 36.26%-2.62M | -100.24%-12.6K | -121.71%-1.53M | -93.74%782.68K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -100.27%-2.82K | -121.45%-147.65K | 66.18%-237.78K | 104.14%777.14K | 96.87%-236.59K | 38.52%1.03M | 111.45%688.37K | 88.17%-703.02K | 49.82%-18.78M | 68.55%-7.57M |
| Capital expenditure reported | 65.87%-57.82K | ---- | ---- | ---- | ---- | ---169.43K | ---- | ---- | ---- | ---- |
| Net PPE purchase and sale | -92.04%24.29K | --0 | --0 | 2,152.76%1.24M | 189,432.46%507.95K | 41,914.88%305.03K | 3,189.50%427.15K | 89.73%-4.86K | 90.48%-60.18K | 100.06%268 |
| Net other investing changes | -96.56%30.71K | -60.32%413.99K | 65.94%-237.78K | 97.55%-458.13K | 77.60%-1.7M | 20.37%892.77K | 117.39%1.04M | 88.16%-698.16K | 49.12%-18.72M | 67.91%-7.57M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -100.27%-2.82K | -121.45%-147.65K | 66.18%-237.78K | 104.14%777.14K | 96.87%-236.59K | 38.52%1.03M | 111.45%688.37K | 88.17%-703.02K | 49.82%-18.78M | 68.55%-7.57M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 418.26%688.3K | -133.06%-503.48K | -1,722.18%-494.12K | -81.91%3.72M | -71.30%2.09M | -95.17%132.81K | -81.79%1.52M | -101.25%-27.12K | -31.64%20.59M | 385.01%7.3M |
| Net issuance payments of debt | 6,351.56%688.3K | -1,339.09%-503.48K | -1,722.18%-494.12K | -83.88%2.02M | 1,847.41%2.1M | -100.44%-11.01K | -100.43%-34.99K | -101.36%-27.12K | 2,598.71%12.54M | -302.22%-119.91K |
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --144.51K | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | -99.59%2.22K | --2.22K | --0 | --0 | --0 | -69.37%545.08K | --0 |
| Net other financing activities | ---- | ---- | ---- | -77.34%1.7M | -76.18%1.77M | ---694 | ---- | ---- | -74.00%7.5M | 5,020.76%7.42M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 418.26%688.3K | -133.06%-503.48K | -1,722.18%-494.12K | -81.91%3.72M | -71.30%2.09M | -95.17%132.81K | -81.79%1.52M | -101.25%-27.12K | -31.64%20.59M | 385.01%7.3M |
| Net cash flow | ||||||||||
| Beginning cash position | -88.37%28.87K | -32.85%292.67K | -49.58%599.21K | 28.33%1.19M | -67.61%245.74K | -64.42%248.27K | -81.76%435.85K | 28.33%1.19M | -9.83%926.06K | -93.48%758.69K |
| Current changes in cash | 266.16%428.67K | 34.55%-268.74K | 63.79%-268.95K | -531.57%-1.19M | -57.47%216.76K | -676.07%-257.98K | 76.70%-410.61K | -150.03%-742.73K | 198.69%276.79K | 105.06%509.72K |
| Effect of exchange rate changes | -45.32%139.67K | -97.79%4.93K | -280.77%-37.58K | 4,301.03%605.33K | 270.95%136.71K | 1,483.62%255.45K | 214.10%223.03K | 54.25%-9.87K | -108.03%-14.41K | 87.49%-79.97K |
| End cash Position | 143.03%597.21K | -88.37%28.87K | -32.85%292.67K | -49.58%599.21K | -49.58%599.21K | -67.61%245.74K | -64.42%248.27K | -81.76%435.85K | 28.33%1.19M | 28.33%1.19M |
| Free cash from | 80.19%-314.62K | 94.73%-179.25K | 2,751.90%462.94K | -259.88%-5.71M | -190.07%-705.17K | 53.91%-1.59M | 17.64%-3.4M | -100.34%-17.46K | -125.05%-1.59M | -93.45%782.95K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.